Registration number: 09089810

Specialist Surgical Services (UK) Ltd

Contents

Balance Sheet	1
Notes to the Unaudited Financial Statements	2 to 8

Specialist Surgical Services (UK) Ltd

(Registration number: 09089810)
Balance Sheet as at 30 June 2025

	Note	2025 £	2024 £
Fixed assets
Intangible assets	5	4,196	5,855
Tangible assets	6	72,803	3,236
Other financial assets	7	953,082	858,525
		1,030,081	867,616
Current assets
Debtors	8	141,330	100,371
Cash at bank and in hand		39,888	102,360
		181,218	202,731
Creditors: Amounts falling due within one year	9	(65,938)	(97,348)
Net current assets		115,280	105,383
Total assets less current liabilities		1,145,361	972,999
Provisions for liabilities		(9,198)	(809)
Net assets		1,136,163	972,190
Capital and reserves
Called up share capital	10	110	110
Retained earnings		1,136,053	972,080
Shareholders' funds		1,136,163	972,190

For the financial year ending 30 June 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

•	The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and
•	The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and FRS 102 ‘The Financial Reporting Standard Applicable in the UK and Republic of Ireland’.

Approved and authorised by the Board on 28 November 2025 and signed on its behalf by:
 

......................................... Dr Joby Jacob George Malal Director

Specialist Surgical Services (UK) Ltd

Notes to the Unaudited Financial Statements for the Year Ended 30 June 2025

1	General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
124 City Road
London
EC1V 2NX
United Kingdom

These financial statements were authorised for issue by the Board on 28 November 2025.

2	Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Specialist Surgical Services (UK) Ltd

Notes to the Unaudited Financial Statements for the Year Ended 30 June 2025

Deferred tax is recognised in respect of all timing differences between taxable profits and profits reported in the financial statements.

Unrelieved tax losses and other deferred tax assets are recognised when it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class	Depreciation method and rate
Plant and machinery	Straight line method at 20.0%
Motor vehicles	Straight line method at 25.0%
Computer equipment	Straight line method at 33.3%

Goodwill

Goodwill arising on the acquisition of an entity represents the excess of the cost of acquisition over the company’s interest in the net fair value of the identifiable assets, liabilities and contingent liabilities of the entity recognised at the date of acquisition. Goodwill is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is held in the currency of the acquired entity and revalued to the closing rate at each reporting period date. Goodwill is amortised over its useful life, which shall not exceed ten years if a reliable estimate of the useful life cannot be made.

Amortisation

Amortisation is provided on intangible assets so as to write off the cost, less any estimated residual value, over their useful life as follows:

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Specialist Surgical Services (UK) Ltd

Notes to the Unaudited Financial Statements for the Year Ended 30 June 2025

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

3	Staff numbers

The average number of persons employed by the company (including directors) during the year, was 3 (2024 - 2).

4	Profit before tax

Arrived at after charging/(crediting)

	2025 £	2024 £
Depreciation expense	9,281	2,131
Amortisation expense	1,660	1,659

Specialist Surgical Services (UK) Ltd

Notes to the Unaudited Financial Statements for the Year Ended 30 June 2025

5	Intangible assets

	Goodwill  £	Internally generated software development costs  £	Total £
Cost or valuation
At 1 July 2024	10,600	5,994	16,594
At 30 June 2025	10,600	5,994	16,594
Amortisation
At 1 July 2024	9,540	1,199	10,739
Amortisation charge	1,060	599	1,659
At 30 June 2025	10,600	1,798	12,398
Carrying amount
At 30 June 2025	-	4,196	4,196
At 30 June 2024	1,060	4,795	5,855

6	Tangible assets

	Furniture, fittings and equipment  £	Motor vehicles  £	Total £
Cost or valuation
At 1 July 2024	33,621	-	33,621
Additions	6,087	72,761	78,848
At 30 June 2025	39,708	72,761	112,469
Depreciation
At 1 July 2024	30,385	-	30,385
Charge for the year	2,608	6,673	9,281
At 30 June 2025	32,993	6,673	39,666
Carrying amount
At 30 June 2025	6,715	66,088	72,803
At 30 June 2024	3,236	-	3,236

Specialist Surgical Services (UK) Ltd

Notes to the Unaudited Financial Statements for the Year Ended 30 June 2025

7	Other financial assets (current and non-current)

	Financial assets at fair value through profit and loss £	Total £
Non-current financial assets
Cost or valuation
At 1 July 2024	858,525	858,525
Fair value adjustments	2,666	2,666
Additions	91,891	91,891
At 30 June 2025	953,082	953,082
Impairment
Carrying amount
At 30 June 2025	953,082	953,082

8

Debtors

Current	2025 £	2024 £
Prepayments	13,647	10,833
Other debtors	127,683	89,538
	141,330	100,371

9

Creditors

Creditors: amounts falling due within one year

	2025 £	2024 £
Due within one year
Taxation and social security	63,141	87,013
Accruals and deferred income	1,274	3,000
Other creditors	1,523	7,335
	65,938	97,348

10	Share capital

Allotted, called up and fully paid shares

Specialist Surgical Services (UK) Ltd

Notes to the Unaudited Financial Statements for the Year Ended 30 June 2025

	2025		2024
	No.	£	No.	£
Ordinary A share of £1 each	70	70	70	70
Ordinary B share of £1 each	30	30	30	30
Ordinary C share of £1 each	10	10	10	10
	110	110	110	110

11

Dividends

Interim dividends paid

		2025 £		2024 £
Interim dividend of £Nil (2024 - £85.71) per each Ordinary A share		-		6,000
Interim dividend of £Nil (2024 - £833.33) per each Ordinary B share		-		25,000
Interim dividend of £6,000.00 per each Ordinary C share		60,000		60,000
		60,000		91,000

12	Related party transactions

Transactions with directors

2025	At 1 July 2024 £	Advances to director £	Other payments made to company by director £	At 30 June 2025 £
Dr Joby Jacob George Malal
Director loan	(5,782)	15,782	(4,640)	5,360
	-	-	-	-
	(5,782)	15,782	(4,640)	5,360
Dr Asha Philip
Director loan	-	10,000	(131)	9,869
	-	-	-	-
	-	10,000	(131)	9,869

Directors' remuneration

The directors' remuneration for the year was as follows:

Specialist Surgical Services (UK) Ltd

Notes to the Unaudited Financial Statements for the Year Ended 30 June 2025

	2025 £	2024 £
Contributions paid to money purchase schemes	75,000	30,000